How can I stimulate Insulin-like Growth Factor 1 (IGF-1) production in my body?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Stimulate IGF-1 Production

The most effective and safest way to increase your IGF-1 levels is through optimizing your nutritional status—specifically ensuring adequate caloric intake, sufficient protein consumption, and maintaining a healthy body weight—as IGF-1 production signals nutrient availability and responds promptly to nutritional refeeding. 1

Natural Methods to Increase IGF-1

Nutritional Optimization (First-Line Approach)

Adequate energy intake is the primary driver of IGF-1 production. IGF-1 is produced predominantly by the liver in response to growth hormone, and its production signals the availability of nutrients needed for anabolic actions. 1

  • Ensure sufficient total caloric intake: IGF-1 concentrations fall dramatically in malnutrition and respond promptly to refeeding. 1
  • Consume adequate protein: Amino acids activate nutrient-sensing pathways (particularly the mTOR pathway) that stimulate IGF-1 production. 2
  • Include carbohydrates: Carbohydrates activate the insulin/IGF-1 signaling pathway, though excessive intake may have long-term health trade-offs. 2

Body Weight Management

Maintaining a healthy body weight is critical for optimal IGF-1 levels. 2

  • Underweight states and energy deficiency suppress IGF-1 production, creating a state of growth hormone resistance. 2
  • In amenorrheic athletes with low energy availability, IGF-1 levels are characteristically low despite elevated growth hormone. 2
  • Weight restoration in energy-deficient states increases IGF-1 more effectively than any pharmacological intervention. 2

Physical Activity Considerations

  • Regular physical activity is important for overall health, but excessive exercise without adequate caloric compensation can suppress IGF-1. 2
  • Energy availability (dietary intake minus exercise expenditure) must be sufficient to support IGF-1 production. 2

Pharmacological Methods (Medical Supervision Required)

Growth Hormone Therapy

Growth hormone is the most potent stimulator of systemic IGF-1 levels, working by directly stimulating hepatic IGF-1 production. 3

  • Growth hormone administration increases serum IGF-1 and lean body mass in clinical studies. 3
  • However, this therapy is expensive and associated with significant side effects including salt and water retention, impaired glucose metabolism, and when used chronically in excess, can lead to cardiac complications. 3
  • This is a prescription medication requiring medical supervision and is only indicated for specific medical conditions like growth hormone deficiency. 2, 4

Direct IGF-1 Replacement

Recombinant human IGF-1 (rhIGF-1) directly increases IGF-1 levels and bone formation markers. 2, 3

  • In clinical trials, rhIGF-1 combined with estrogen led to a 2.8% increase in bone mineral density in women with anorexia nervosa. 2, 3
  • This is an experimental therapy not widely available and requires medical supervision. 2

Anabolic Steroids

  • Low-dose anabolic steroids may increase IGF-1 through interaction with the IGF-1 system and regulation of the myostatin gene. 3
  • These are controlled substances with significant side effects and legal restrictions. 3

Critical Warnings and Contraindications

Cancer Risk Considerations

Chronically elevated IGF-1 levels are associated with increased cancer risk. 2, 5

  • Overweight and obesity increase cancer risk partly through elevated IGF-1 and insulin levels. 2
  • Epidemiological evidence suggests that elevated IGF-1 is related to increased risk of colon, pancreatic, endometrial, breast, and prostate cancers. 5
  • People with acromegaly (pathologically elevated growth hormone and IGF-1) have a two- to threefold increase in mortality, mostly from vascular disease. 2

Cardiovascular Risks

  • Chronic excess GH and IGF-1 secretion results in biventricular cardiac hypertrophy and can progress to dilated cardiomyopathy. 3
  • Individuals with acromegaly have significantly increased cardiovascular mortality. 2, 6

Metabolic Effects

  • While IGF-1 has insulin-like effects that can lower blood glucose, growth hormone (which stimulates IGF-1) causes insulin resistance and hyperglycemia. 7, 8

Factors That Suppress IGF-1 (Avoid These)

  • Oral estrogen: Suppresses hepatic IGF-1 production through first-pass liver metabolism. 2, 3
  • Severe hypothyroidism: Suppresses IGF-1 generation. 2, 6
  • Malnutrition or severe caloric restriction: Creates growth hormone resistance with low IGF-1. 2, 6, 1
  • Severe infection: Acutely suppresses IGF-1 levels. 2

Practical Clinical Algorithm

  1. Assess your current nutritional status: Are you consuming adequate calories and protein for your activity level? 1
  2. Evaluate body weight: If underweight or in negative energy balance, focus on nutritional rehabilitation first. 2
  3. Optimize macronutrient intake: Ensure adequate protein (amino acids) and total energy intake. 2, 1
  4. Balance exercise with nutrition: If highly active, ensure energy availability is sufficient. 2
  5. Consider medical evaluation only if: You have documented growth hormone deficiency or other specific medical conditions requiring treatment. 2, 4

The key pitfall to avoid is pursuing artificially elevated IGF-1 levels beyond physiological norms, as this increases long-term risks of cancer and cardiovascular disease. 2, 5 The goal should be optimizing IGF-1 within the normal physiological range through healthy nutrition and lifestyle, not supraphysiological elevation through pharmacological means.

References

Research

Insulin-like growth factor-I (IGF-I) and clinical nutrition.

Clinical science (London, England : 1979), 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Effect of Peptide Therapy on IGF-1 Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

How to use insulin-like growth factor 1 (IGF1).

Archives of disease in childhood. Education and practice edition, 2012

Guideline

Evaluation of Elevated IGF-1 Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1.

Nature clinical practice. Endocrinology & metabolism, 2007

Research

Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes.

Endocrinology and metabolism clinics of North America, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.